Search

Search Results

• Successful Treatment of Refractory Immune Thrombotic Thrombocytopenic Purpura with Daratumumab

  E.E. Klebanova, Gennadii Martinovich Galstyan, S.Yu. Mamleeva, D.K. Bessmertnyy, Z.T. Fidarova, E.N. Parovichnikova

  270-276

  01.07.2025

• Anti-CD38 Antibodies in Monotherapy for Patients with Relapsed/Refractory Multiple Myeloma: Real-World Clinical Practice and Results of Clinical Trials

  Margarita Andreevna Ulyanova, V.I. Vorobyev, L.A. Bychenkova, S.V. Semochkin

  145-152

  01.04.2025

• Functional Cure as a New Concept of Therapy for Multiple Myeloma

  Sergei Vyacheslavovich Semochkin

  105-120

  01.04.2025

• Sarcoid-like Pulmonary Lesion in a Female Patient with Multiple Myeloma and Systemic AL Amyloidosis Treated with Daratumumab: A Case of Spontaneous Regression of Lung Tissue Changes upon Drug Withdrawal

  Irina Germanovna Rekhtina, V.A. Khyshova, A.M. Kovrigina, M.A. Silaev, L.P. Mendeleeva

  370-375

  01.10.2024

• Perspectives for the Use of Immunomodulatory Drugs and Cereblon E3 Ligase Modulators in the Treatment of Multiple Myeloma

  Sergei Vyacheslavovich Semochkin

  229-241

  09.06.2023

• Plasmablastic Lymphoma with Primary Impairment of Bone Marrow in a HIV-Negative Patient: A Literature Review and a Case Report

  Maiya Valerevna Firsova, M.V. Solov’ev, A.M. Kovrigina, L.P. Mendeleeva

  356-364

  01.10.2022

• Clinical Efficacy of Daratumumab in Monotherapy of Relapsed/Refractory Multiple Myeloma

  Stanislav Semenovich Bessmeltsev, E.V. Karyagina, E.Yu. Ilyushkina, Zh.L. Stolypina, R.R. Miftakhova, I.I. Kostroma, T.L. Shelkovskaya

  25-32

  01.01.2020

• New Possibilities of Treatment for Relapsed/Refractory Multiple Myeloma: A Literature Review

  Ol’ga Mikhailovna Votyakova

  425-434

  01.10.2017